What is a T4 (thyroid hormone level 4) score for a hit panel in drug discovery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

T4 Score in HIT Panel

The "T4 score" you're asking about does not exist in the context of HIT (Heparin-Induced Thrombocytopenia) diagnosis. You are likely referring to the "4Ts score," which is a clinical prediction tool used to estimate the pretest probability of HIT in patients with suspected disease. 1

What is the 4Ts Score?

The 4Ts score is a standardized clinical scoring system that evaluates four key components to assess HIT probability 1:

  • Thrombocytopenia (degree and timing of platelet count fall)
  • Timing of platelet count fall (relative to heparin exposure)
  • Thrombosis or other sequelae
  • Other causes of thrombocytopenia (whether alternative explanations exist)

Score Interpretation and Clinical Action

The 4Ts score stratifies patients into three risk categories that directly determine management 1:

Low Probability (4Ts score ≤ 3)

  • Do not order HIT laboratory testing 1
  • Do not discontinue heparin or initiate non-heparin anticoagulants 1
  • Continue or resume heparin if clinically indicated 1

Intermediate Probability (4Ts score 4-5)

  • Discontinue all heparin immediately 1
  • Initiate non-heparin anticoagulant at therapeutic intensity if not at high bleeding risk 1
  • Use prophylactic intensity if high bleeding risk present 1
  • Obtain immunoassay testing 1

High Probability (4Ts score 6-8)

  • Discontinue all heparin immediately 1
  • Initiate non-heparin anticoagulant at therapeutic intensity 1
  • Obtain immunoassay testing 1

Diagnostic Algorithm Following 4Ts Scoring

For intermediate or high 4Ts scores, the American Society of Hematology recommends a sequential testing approach 1:

  1. First: Immunoassay (preferably PF4/heparin ELISA with low threshold) 1

    • If positive: Continue non-heparin anticoagulant at therapeutic intensity 1
    • If negative: Discontinue non-heparin anticoagulant and resume heparin if indicated 1
  2. Second: Functional assay (if immunoassay positive and available) 1

    • Exception: May skip functional assay if high 4Ts score AND strongly positive ELISA (≥2.0 OD units) 1
    • If functional assay positive: HIT confirmed 1
    • If functional assay negative: HIT unlikely 1

Critical Practice Points

Missing or inaccurate information leads to faulty 4Ts scores and inappropriate management 1. When key clinical data is unavailable, err toward a higher 4Ts score to avoid missing true HIT cases 1.

Reassess patients frequently and recalculate the 4Ts score if the clinical picture changes 1.

The 4Ts score is superior to gestalt (unstructured clinical judgment) for HIT diagnosis 1. Using gestalt instead of the 4Ts score results in 478 more patients receiving unnecessary non-heparin anticoagulants with attendant bleeding risks 1.


Note: If you were asking about T4 (thyroxine/thyroid hormone) in relation to heparin testing, heparin can interfere with thyroid function tests, and blood samples should be collected at least 4 hours after stopping unfractionated heparin or ≥12 hours after low molecular weight heparin 2. However, this is unrelated to HIT diagnosis.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Heparin's Effect on Thyroxine Test Results

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.